Lilly (https://t.co/Ufzh5ZwPsH) plans to acquire Adverum (https://t.co/LdWmKZ9gWS) and its gene therapy Ixo-vec.
Offer: $3.56/share + up to $8.91 CVR, valuing the deal at $12.47/share.
Adverum develops single-dose intravitreal therapies for wAMD.
On Oct. 24, U.S. September CPI rose 3.0% YoY (core 3.0%), below expectations.
Markets reacted mildly bullish: dollar down 0.3%, gold up $30 to $4089/oz ahead of the Fed meeting.
Genenta Science (NASDAQ:GNTA) surged 241.8% premarket after partnering with ANEMOCYTE on lentiviral vector plasmid DNA. CEO Paracchi said the deal supports scalable advanced therapy development.
https://t.co/BJItKtUppF โ Vivakor (NASDAQ:VIVK) rose 50% premarket ahead of the ThinkEquity conference.
CEO James Ballengee will speak and meet investors.
The company provides sustainable energy transport and oilfield services.
https://t.co/BJItKtUppF โ Brazilโs mid-October inflation fell to 5.0% YoY (Sep: 5.3%), 0.2% MoM.
Food & housing eased; transport rose.
Central bank stays hawkish at 15.00%.
๐ฐ Sierra Bancorp (BSRR) +7.2%
๐ New buyback: up to 1M shares (Nov 2025โOct 2026)
๐ต Quarterly dividend: $0.25/share, 107th consecutive since 1987
๐ฅ JPMorgan Raises Gold Target to $3,850
๐ Up from $2,100 (+80%) due to macro and monetary shifts.
โ๏ธ Recommends holding gold miners, >50% upside by Dec 2027.
๐ฌ Surge reflects central bank buying and renewed investor interest.
๐ฅ COMEX Silver Stocks Plunge
๐ฌ Ex-metals banker Bob Gottlieb says 29M oz of silver exited COMEX in two weeks, showing delivery stress and a structural shift in goldโs role.
๐ JPMorgan to Accept Bitcoin & Ether as Collateral
๐ช JPMorgan (https://t.co/1oBeV0OlmE) will let institutions use Bitcoin and Ether for loans by year-end, marking deeper crypto integration on Wall Street.